4.5 Review

Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19

Xin Tong et al.

Summary: COVID-19 is associated with an increased risk of venous thromboembolism (VTE). This study examined the prevalence of VTE among acute ischaemic stroke (AIS) patients with and without a history of COVID-19. The results showed a higher prevalence of VTE among patients with a history of hospitalised or non-hospitalised COVID-19 compared to those without a history of COVID-19.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Expediting the drug discovery for ideal leads against SARS-CoV-2 via molecular docking of repurposed drugs

Akanksha Sharma et al.

Summary: SARS-CoV-2, the novel coronavirus, has prompted the urgent need for repurposing drugs to combat the global pandemic. In this study, molecular docking was used to evaluate the potential inhibitory effects of five FDA approved repurposed drugs against SARS-CoV-2 proteins. Umifenovir and Pregnenolone showed potential as inhibitors for most of the proteins. These drugs should be further studied in vitro and in vivo due to their high binding affinity. Communicated by Ramaswamy H. Sarma.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Cell Biology

Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus

Jiaxi Xu et al.

Summary: The recent outbreak of COVID-19 caused by the novel coronavirus SARS-CoV-2 has spread rapidly worldwide. Similar to SARS-CoV, this new coronavirus utilizes ACE2 as an entry point to cells. Growing evidence suggests that COVID-19 patients, particularly those in severe condition, exhibit neurological symptoms, indicating the potential for SARS-CoV-2 to infect and damage neurons in the central nervous system. By studying human neurons derived from pluripotent stem cells, we have demonstrated the expression of ACE2 in human neurons. This highlights the importance of considering the neuro-invasive potential of SARS-CoV-2 as both a contributing factor and a therapeutic target for the severe respiratory symptoms in critical COVID-19 cases.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Article Cell Biology

SARS-CoV-2 Infectivity and Neurological Targets in the Brain

Walter J. Lukiw et al.

Summary: The novel coronavirus SARS-CoV-2 enters human host cells through the ACE2 receptor, allowing it to attack multiple cell types simultaneously and cause harm to various tissues and organ systems. This study found that ACE2 is highly expressed not only in respiratory, digestive, renal-excretory, and reproductive cells, but also in regions of the brain such as the amygdala, cerebral cortex, and brainstem. The high expression of ACE2 in the brainstem, particularly in the respiratory centers, may explain the susceptibility of COVID-19 patients to severe respiratory distress.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Review Dermatology

Skin manifestations associated with COVID-19

Camila Arai Seque et al.

Summary: This article addresses the main aspects of skin manifestations associated with COVID-19 based on a literature review. The actual frequency of dermatological manifestations remains uncertain, but maculopapular eruptions and erythema pemio-like lesions are considered the most frequent presentations. The time of onset, severity, and prognosis vary according to the clinical presentation pattern. Histopathological descriptions and the relationship between COVID-19 and androgens have also been studied.

ANAIS BRASILEIROS DE DERMATOLOGIA (2022)

Review Biochemistry & Molecular Biology

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Yizhou Jiang et al.

Summary: This review summarizes the mechanism of SARS-CoV-2 infection and the subsequent immunological events related to excessive cytokine production and inflammatory responses associated with ACE2-AngII signaling. An overview of the diagnosis and an update on current therapeutic regimens and vaccinations are also provided.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Clinical Neurology

Long-term effects of COVID-19 on mental health: A systematic review

Nicole Wallbridge Bourmistrova et al.

Summary: The systematic review found that most participants experienced mild or no anxiety and depression symptoms in the long-term mental health outcomes after COVID-19 infection. Sleep disturbances were primarily reported as mild, and the prevalence of PTSD was similar to anxiety and depression.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Article Neurosciences

Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic

Yimin Chen et al.

Summary: This study successfully shortened the door-to-needle time for acute ischemic stroke patients receiving intravenous recombinant tissue plasminogen activator treatment through multidisciplinary collaboration and process optimization, achieving significant improvement.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2022)

Review Clinical Neurology

COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era

Arens Taga et al.

Summary: This study reviewed the literature on the potential association between COVID-19, COVID-19 vaccines, and peripheral nervous system (PNS) manifestations. While PNS complications have been reported in relation to COVID-19 and COVID-19 vaccines, the evidence for a pathophysiological correlation remains limited and further epidemiological and pathological data are needed.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Cell & Tissue Engineering

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS route for SARS-CoV-2

Susanne Krasemann et al.

Summary: Neurological complications are common in COVID-19. This study reveals that SARS-CoV-2 can enter the brain through the blood-brain barrier and cause increased interferon signaling. In vitro experiments show that SARS-CoV-2 can infect BCECs and replicate, with the virus being transported across the barrier. This process can be inhibited by specific antibodies or inhibitors.

STEM CELL REPORTS (2022)

Review Clinical Neurology

Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist

Kevin C. J. Yuen et al.

Summary: Sodium and water perturbations are common in patients who had an acute stroke, with various contributing factors such as underlying comorbidities and medications. COVID-19 infection may exacerbate this condition, leading to worse outcomes.

STROKE AND VASCULAR NEUROLOGY (2022)

Review Pharmacology & Pharmacy

Neurological manifestations of long-COVID syndrome: a narrative review

Maria-Ioanna Stefanou et al.

Summary: Accumulating evidence suggests a high prevalence of prolonged neurological symptoms among COVID-19 survivors. 'Long-COVID' is conceptualized as a multi-organ disorder with a wide range of clinical manifestations. Neuroinflammatory and oxidative stress processes are thought to be involved in the development of neurological sequelae. Collaborative research initiatives are urgently needed to expedite the development of preventive and therapeutic strategies for these symptoms.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2022)

Article Biochemistry & Molecular Biology

In silico characterization of mutations circulating in SARS-CoV-2 structural proteins

Neha Periwal et al.

Summary: The SARS-CoV-2 genome has 61 mutations concentrated in three protein coding genes. Computational tools were used to study the impact of mutations on the functionality, stability, and flexibility of structural proteins.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biology

SARS-CoV-2 Infection and Pancreatic β Cell Failure

Keiichiro Mine et al.

Summary: This article provides a comprehensive review of the potential association between SARS-CoV-2 infection or COVID-19 and pancreatic beta-cell damage leading to the onset of diabetes. It discusses the findings from published studies and highlights the need for further research in understanding the pathogenesis of diabetes mellitus.

BIOLOGY-BASEL (2022)

Review Clinical Neurology

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

Rodolfo Furlan Damiano et al.

Summary: Recent attention has been focused on the impact of infectious diseases on human cognition, with theories proposed to explain cognitive decline. Studies suggest that COVID-19 may have short- and long-term effects on cognition, even in asymptomatic individuals.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Article Neurosciences

Inflammation at the crossroads of COVID-19, cognitive deficits and depression

Natalia M. Lyra e Silva et al.

Summary: COVID-19 infection is associated with acute neurological alterations and long-term neurological abnormalities, with ongoing research investigating the mechanisms behind these impacts, particularly neuroinflammation and blood-brain barrier dysfunction. Survivors of COVID-19 may have an increased risk of developing dementia and mood disorders.

NEUROPHARMACOLOGY (2022)

Review Neurosciences

Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

Hema Kumari Alajangi et al.

Summary: The integrity of the blood-brain barrier (BBB) is crucial for the normal functioning of the central nervous system (CNS). Nanotechnology-based approaches are being explored as alternatives to conventional methods for treating neurological diseases caused by BBB disruption. It is important to understand the characteristics of BBB for the discovery of new drugs that can effectively cross the barrier. This article discusses the building blocks of BBB, immune response activation upon breach of the barrier, autoimmune neurological disorders caused by BBB dysfunction, mechanisms of transport pathways across BBB, and novel strategies and alternative routes for drug delivery into CNS.

MOLECULAR BRAIN (2022)

Review Immunology

COVID-19 and cognitive impairment: neuroinvasive and blood-brain barrier dysfunction

Yanting Chen et al.

Summary: COVID-19, caused by SARS-CoV-2, may invade the brains of patients and cause cognitive impairment. The virus can affect cranial nerves and potentially interact with the brain through infected nerve endings and the blood-brain barrier.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Microbiology

Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations

Neha Periwal et al.

Summary: We performed a time series analysis on SARS-CoV-2 genomic sequences to understand the kinetics of mutations in the viral genomes. We identified significant mutations and comutations that may contribute to viral replication and fitness. Certain mutations were found to be correlated and grouped together in a cluster. Additionally, we observed the effects of specific mutations on the stability of viral proteins.

MICROBIOLOGY SPECTRUM (2022)

Article Health Care Sciences & Services

The Impact of COVID-19 Pandemic on Ischemic Stroke Patients in a Comprehensive Hospital

Yimin Chen et al.

Summary: The study investigated the impact and outcomes of characteristic ischemic stroke during the COVID-19 pandemic lockdown. The results showed that patients during the lockdown period had longer door-to-CT time and higher hospitalization costs compared to the pre-lockdown period, but there were no significant differences in 3-month outcomes. Therefore, multidisciplinary collaboration and continuous workflow optimization are necessary to maintain stroke care during the COVID-19 lockdown.

RISK MANAGEMENT AND HEALTHCARE POLICY (2022)

Article Psychiatry

Predictors of mental health deterioration from pre- to post-COVID-19 outbreak

Nathaly Rius Ottenheim et al.

Summary: The study found neuroticism to be a robust predictor of adverse changes in mental health, and identified additional sociodemographic and COVID-19-related predictors that explain longitudinal variability in mental health during the COVID-19 pandemic.

BJPSYCH OPEN (2022)

Letter Parasitology

Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19

Marzia Puccioni-Sohler et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2022)

Review Biochemistry & Molecular Biology

Immune response and blood-brain barrier dysfunction during viral neuroinvasion

Zhuangzhuang Chen et al.

Summary: The blood-brain barrier (BBB) is crucial for maintaining brain homeostasis, composed of specialized brain microvascular endothelial cells joined by tight junctions. Infection with neurotropic viruses may disrupt BBB structure and function, activating immune responses. Exploring the interaction between host and pathogen at the BBB helps propose new treatments for viral encephalitis.

INNATE IMMUNITY (2021)

Article Immunology

Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study

Andrea Pilotto et al.

Summary: SARS-CoV-2 infection is associated with a wide spectrum of encephalitis characterized by different clinical presentations, response to treatment, and outcomes. The study identified subtypes of encephalitis based on MRI results, with patients showing acute demyelinating encephalomyelitis and limbic encephalitis having a delayed onset and more severe COVID-19 respiratory involvement. Patients with MRI alterations exhibited worse response to treatment and final outcomes.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Clinical Neurology

The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning

Gabriel A. de Erausquin et al.

Summary: The impact of SARS-CoV-2 on the central nervous system has raised concerns about the risk of later life cognitive decline, Alzheimer's disease, and other dementia. An international consortium has been formed to study the short and long-term consequences of the virus on the CNS and enroll individuals for evaluations to better understand the underlying biology contributing to AD and dementia.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV-2

Lauren A. Beslow et al.

Summary: This study aimed to determine the proportion of pediatric SARS-CoV-2 cases with ischemic stroke and found that only a small percentage of pediatric SARS-CoV-2 cases develop stroke, with a low proportion testing positive for SARS-CoV-2.

ANNALS OF NEUROLOGY (2021)

Article Clinical Neurology

The Impact of SARS-CoV-2 on Stroke Epidemiology and Care: A Meta-Analysis

Aristeidis H. Katsanos et al.

Summary: This study found that patients with SARS-CoV-2 infection have an increased risk of ischemic stroke and higher mortality rates.

ANNALS OF NEUROLOGY (2021)

Article Clinical Neurology

Ischemic Stroke in Patients with COVID-19 Disease: A Report of 10 Cases from Iran

Sanaz Ahmadi Karvigh et al.

Summary: Ischemic strokes in COVID-19 patients tend to occur as large infarcts and can be seen in patients with mild to moderate pulmonary involvement, with most patients not showing fever upon admission for stroke.

CEREBROVASCULAR DISEASES (2021)

Review Immunology

The blood-brain barrier in systemic infection and inflammation

Ian Galea

Summary: The vascular blood-brain barrier serves as a regulated interface between the blood and brain, protecting neurons and signaling inflammation and infection to the brain. As systemic inflammation exacerbates, the barrier becomes more permeable, leading to increased lymphocyte trafficking and potential endothelial cell damage. Further research is needed to understand the varied response of the blood-brain barrier to systemic inflammation.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Immunology

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Eric Song et al.

Summary: The study showed through three approaches that SARS-CoV-2 is capable of infecting brain neurons, leading to metabolic changes and pathological features without triggering type I interferon responses. These results provide evidence for the neuroinvasive capacity of SARS-CoV-2 and the unexpected consequence of direct infection of neurons by the virus.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Review Neuroimaging

Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist

Amanda Zakeri et al.

Summary: COVID-19 is caused by SARS-CoV-2, leading to arterial thrombosis in some patients. This review provides a brief overview of the disease, the mechanisms of COVID-19-associated coagulopathy, and the impact of COVID-19 on ischemic stroke.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2021)

Review Neurosciences

Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?

Vladimir N. Uversky et al.

Summary: SARS-CoV-2 infection can lead to neurological symptoms and may enter the nervous system through blood endothelial cells, causing neurological dysfunction.

JOURNAL OF NEUROSCIENCE RESEARCH (2021)

Review Physiology

Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients

Sebastian Voicu et al.

Summary: COVID-19 patients, especially those in critical condition, are predisposed to deep vein thrombosis and pulmonary embolism. The inflammatory and prothrombotic phenotype in these patients is marked by increased levels of certain proteins and factors. This, along with venous stasis, significantly raises the risk of thrombosis in critically ill COVID-19 patients.

FRONTIERS IN PHYSIOLOGY (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders

Narayanappa Amruta et al.

Summary: SARS-CoV-2 is a novel coronavirus that causes the COVID-19 pandemic and severely affects the respiratory system, impacting the central nervous system as well. Older individuals with underlying neurological conditions such as stroke, Alzheimer's disease, and Parkinson's disease are more likely to experience complications associated with COVID-19.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Review Neurosciences

Basal lamina changes in neurodegenerative disorders

Benjamin Nguyen et al.

Summary: This article focuses on the changes of the basal lamina (BL) during aging and in neurodegenerative disorders, and its impact on the blood-brain barrier and meningeal lymphatic/glymphatic system. Research has revealed the crucial role of the BL in the pathogenesis and progression of neurodegenerative disorders.

MOLECULAR NEURODEGENERATION (2021)

Review Biochemistry & Molecular Biology

Interactions of SARS-CoV-2 with the Blood-Brain Barrier

Michelle A. Erickson et al.

Summary: This review discusses the mechanisms by which SARS-CoV-2 interactions with the blood-brain barrier (BBB) may lead to neurological dysfunction associated with COVID-19. It considers peripheral diseases such as hypoxia and systemic inflammatory response syndrome, as well as CNS infection and viral entry into the brain. Additionally, it explores the contribution of risk factors for severe COVID-19 to BBB dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

Potential mechanisms of cerebrovascular diseases in COVID-19 patients

Manxue Lou et al.

Summary: This review summarizes the impact of COVID-19 infection on cerebrovascular diseases, including ACE2, renin-angiotensin system, neutrophil extracellular traps, inflammatory cascade, antiphospholipid antibodies, and hyperglycemia.

JOURNAL OF NEUROVIROLOGY (2021)

Article Cell & Tissue Engineering

Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids

Anand Ramani et al.

Summary: SARS-CoV-2 targets human neurons and causes neurological symptoms, with human brain organoids playing a key role in research to enhance our understanding of this phenomenon.

STEM CELL REPORTS (2021)

Article Multidisciplinary Sciences

Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement

Batil Alonazi et al.

Summary: During the COVID-19 pandemic, the frequency of neurological manifestations has increased, with brain MRI proving to be a sensitive imaging modality for diagnosing viral encephalitides. The study found significant impact of brain MRI in patients with SARS-CoV-2 pneumonia, especially in those with non-focal neurological manifestations and declining Glasgow Coma Scale (GCS).

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Maxime Taquet et al.

Summary: This study investigated the incidence and co-occurrence of long-COVID features in COVID-19 survivors, with comparisons to influenza patients, using electronic health records data. The findings showed that long-COVID clinical features were more commonly reported after COVID-19 infection, and differences were associated with sex, age, and illness severity.

PLOS MEDICINE (2021)

Article Clinical Neurology

Cognitive impairment and a ered cerebral glucose metabolism in the subacute stage of COVID-19

Jonas A. Hosp et al.

Summary: During the COVID-19 pandemic, a prospective cohort study investigated neurological and cognitive symptoms in hospitalized patients, revealing that gustation and olfaction were commonly affected, along with cognitive impairment. Abnormalities in neuronal metabolism were associated with cognitive decline, highlighting the importance of neurological monitoring in COVID-19 patients.

BRAIN (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development

Mandeep Kaur et al.

Summary: Globally, SARS-CoV-2 poses a threat to life and economy, prompting researchers to search for a cure. This review aims to summarize the functional roles of different domains of the SARS-CoV-2 genome and highlight the importance of finding potential drugs/vaccines.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Review Rheumatology

Systemic and organ-specific immune-related manifestations of COVID-19

Manuel Ramos-Casals et al.

Summary: Immune-related disorders in patients with COVID-19 present with diverse manifestations mimicking various inflammatory and autoimmune diseases, with clinical phenotype influenced by factors like age, sex, and ethnicity. The severity of symptoms varies greatly, from benign to life-threatening, and the pathogenesis and optimal therapy for these manifestations require further research.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Psychiatry

COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders

Mohammad Ali Moni et al.

Summary: Psychiatric symptoms can be observed in COVID-19 patients, but the exact interaction with underlying neuronal or psychiatric susceptibilities is still unclear. Research has shown shared altered signaling and ontology pathways between COVID-19 patients and those with bipolar disorder, PTSD, and schizophrenia, indicating some similarities in disease mechanisms.

TRANSLATIONAL PSYCHIATRY (2021)

Review Pharmacology & Pharmacy

PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP

Kaining Zhi et al.

Summary: The blood-brain barrier poses a challenge to drug delivery into the brain, but PLGA nanoparticles have shown promise in improving drug penetration. The addition of excipients like PEG and PVA can further enhance the stability and effectiveness of PLGA formulations.

PHARMACEUTICS (2021)

Article Neurosciences

Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient

Domenico Nuzzo et al.

Summary: The role of neurologists and neurobiologists in studying key features of brain infection and neurological manifestations of COVID-19 is crucial, with many studies suggesting brain damage and persistent neurological symptoms post-infection. This study highlights the necessity of deepening analysis of persistent neurological signs in patients after a severe clinical condition of COVID-19.

BRAIN SCIENCES (2021)

Article Clinical Neurology

Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study

Linda W. G. Luijten et al.

Summary: In the context of the COVID-19 pandemic, there has been an increase in reports of patients with neurological disorders, including Guillain-Barre syndrome (GBS), following infection with SARS-CoV-2. A prospective observational study investigated the clinical and laboratory signs of SARS-CoV-2 infection in GBS patients and found that those with a confirmed or probable infection often presented with specific neurological features. However, the study suggests that more research, such as a case-control study, is needed to determine if there is a causal link between GBS and SARS-CoV-2.

BRAIN (2021)

Review Clinical Neurology

Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions

Kiran T. Thakur et al.

Summary: This study conducted a collaborative review among a global group of expert neurologists and hematologists to identify strategies for rapid evaluation and treatment of CVT in the context of potential VITT, including measurements of inflammatory markers, PF4 assays, and non-heparin anticoagulation.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Review Primary Health Care

Viral Pandemics in the Past Two Decades: An Overview

Pooja Bhadoria et al.

Summary: A pandemic is a widespread disease that affects a large population globally. There are many different viruses that can infect humans, with potential for even more undiscovered viruses to pose a threat in the future.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration

Ling Zhang et al.

Summary: The study found evidence supporting that SARS-CoV-2 can cross the blood-brain barrier in transcellular pathways based on experiments in mice and hamsters. The transmission pathway involves disrupted basement membrane without obvious alteration of tight junctions.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Endocrinology & Metabolism

Cerebral venous thrombosis in COVID-19

Ritwik Ghosh et al.

Summary: COVID-19 infection may lead to various neurological diseases, among which CVT plays a significant role. The known hypercoagulable state in SARS-CoV-2 infection is believed to be the main mechanism in COVID-19-related CVT.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

Review Immunology

Immune dysregulation and system pathology in COVID-19

Muhammad Jamal et al.

Summary: COVID-19, caused by the novel coronavirus, has led to a global public health crisis with significant confirmed cases and mortalities. Patients exhibit a dysregulated immune response characterized by cytokine storm, increasing the mortality rate. Treatment strategies should focus on antiviral drugs, immunomodulators, and addressing underlying comorbidities.

VIRULENCE (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Review Geriatrics & Gerontology

Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain

William M. Pardridge

FRONTIERS IN AGING NEUROSCIENCE (2020)

Letter Immunology

SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis

Y. Hanna Huang et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Article Microbiology

The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier

Chi-Fen Chiu et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Infectious Diseases

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Takeshi Moriguchi et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Editorial Material Clinical Neurology

Guillain-Barre syndrome related to COVID-19 infection

Paola Alberti et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Public, Environmental & Occupational Health

A qualitative study on the psychological experience of caregivers of COVID-19 patients

Niuniu Sun et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2020)

Article Critical Care Medicine

Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2

Rajiv Dhand et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Critical Care Medicine

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Medical Laboratory Technology

Laboratory Findings in COVID-19 Diagnosis and Prognosis

Atieh Pourbagheri-Sigaroodi et al.

CLINICA CHIMICA ACTA (2020)

Article Neurosciences

Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital

Adalberto Studart-Neto et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2020)

Editorial Material Medicine, General & Internal

Is a Cytokine Storm Relevant to COVID-19?

Pratik Sinha et al.

JAMA INTERNAL MEDICINE (2020)

Article Neurosciences

The COVID-19 Pandemic: Consideration for Brain Infection

Xiao-Yuan Mao et al.

NEUROSCIENCE (2020)

Editorial Material Obstetrics & Gynecology

SARS-CoV-2 and the testis: similarity with other viruses and routes of infection

Walter D. Cardona Maya et al.

REPRODUCTIVE BIOMEDICINE ONLINE (2020)

Review Clinical Neurology

Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports

Kaveh Rahimi

NEUROLOGICAL SCIENCES (2020)

Review Hematology

D-dimer level in COVID-19 infection: a systematic review

Mehrdad Rostami et al.

EXPERT REVIEW OF HEMATOLOGY (2020)

Editorial Material Critical Care Medicine

y Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome

Lorraine B. Ware

LANCET RESPIRATORY MEDICINE (2020)

Article Clinical Neurology

Multiple sclerosis following SARS-CoV-2 infection

M. Palao et al.

Multiple Sclerosis and Related Disorders (2020)

Review Clinical Neurology

Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations

Parmenides Guadarrama-Ortiz et al.

FRONTIERS IN NEUROLOGY (2020)

Article Public, Environmental & Occupational Health

Meningitis as an Initial Presentation of COVID-19: A Case Report

Sidra Naz et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Review Clinical Neurology

COVID-19 and cerebrovascular diseases: a comprehensive overview

Georgios Tsivgoulis et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)

Article Genetics & Heredity

Genomic characterization of a novel SARS-CoV-2

Rozhgar A. Khailany et al.

GENE REPORTS (2020)

Review Clinical Neurology

Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism

Hongyang Fan et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Review Clinical Neurology

Multiple sclerosis - a review

R. Dobson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Multidisciplinary Sciences

Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis

Charlotte Warren-Gash et al.

SCIENTIFIC REPORTS (2019)

Review Chemistry, Multidisciplinary

Crossing the blood-brain barrier with nanoparticles

Yiqun Zhou et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Review Biochemistry & Molecular Biology

Use of Polyamidoamine Dendrimers in Brain Diseases

Maria Florendo et al.

MOLECULES (2018)

Article Endocrinology & Metabolism

Regional hypoxic cerebral vasodilation facilitated by diameter changes primarily in anterior versus posterior circulation

J. Mikhail Kellawan et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)

Article Oncology

Endothelial cell-cell adhesion and signaling

Camilla Cerutti et al.

EXPERIMENTAL CELL RESEARCH (2017)

Article Medicine, General & Internal

Guillain-Barre Syndrome

Eelco F. M. Wijdicks et al.

MAYO CLINIC PROCEEDINGS (2017)

Review Medicine, Research & Experimental

Nanoparticle transport across the blood brain barrier

Andreas M. Grabrucker et al.

TISSUE BARRIERS (2016)

Article Cell Biology

The Blood-Brain Barrier

Richard Daneman et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)

Editorial Material Clinical Neurology

Delirium, dementia and senility

Raj N. Kalaria et al.

BRAIN (2012)

Review Endocrinology & Metabolism

Drug transport across the blood-brain barrier

William M. Pardridge

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Review Clinical Neurology

Vitamin D and multiple sclerosis

Alberto Ascherio et al.

LANCET NEUROLOGY (2010)

Article Clinical Neurology

Characteristics of compounds that cross the blood-brain barrier

William A. Banks

BMC NEUROLOGY (2009)

Editorial Material Neurosciences

Viral Infection Leading to Brain Dysfunction: More Prevalent Than Appreciated?

Anthony N. van den Pol

NEURON (2009)

Review Immunology

The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction

Britta Engelhardt et al.

SEMINARS IN IMMUNOPATHOLOGY (2009)

Review Neurosciences

The relationship between encephalitis lethargica and influenza: A critical analysis

Sherman McCall et al.

JOURNAL OF NEUROVIROLOGY (2008)

Review Cardiac & Cardiovascular Systems

Phenotypic heterogeneity of the endothelium II. Representative vascular beds

William C. Aird

CIRCULATION RESEARCH (2007)

Review Biochemistry & Molecular Biology

Virus entry: Open sesame

M Marsh et al.

Article Biochemistry & Molecular Biology

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

IC Huang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Biochemistry & Molecular Biology

Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses

L Pelkmans

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)

Article Virology

Characterization of the host cell entry of filamentous influenza virus

SB Sieczkarski et al.

ARCHIVES OF VIROLOGY (2005)

Article Immunology

Multiple organ infection and the pathogenesis of SARS

J Gu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Biochemistry & Molecular Biology

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents

F Gembardt et al.

PEPTIDES (2005)

Review Cell Biology

Cargo recognition during clathrin-mediated endocytosis: a team effort

A Sorkin

CURRENT OPINION IN CELL BIOLOGY (2004)

Review Cell Biology

Insider information: what viruses tell us about endocytosis

L Pelkmans et al.

CURRENT OPINION IN CELL BIOLOGY (2003)

Article Virology

Internalization of Echovirus 1 in caveolae

V Marjomäki et al.

JOURNAL OF VIROLOGY (2002)

Review Biochemistry & Molecular Biology

Clathrin coat construction in endocytosis

BMF Pearse et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2000)

Article Medicine, General & Internal

The impact of stroke

CDA Wolfe

BRITISH MEDICAL BULLETIN (2000)